U.S. DEA relaxes production limits on controlled drugs for COVID-19 patients
(Reuters) – The U.S. Drug Enforcement Administration said on Tuesday it was increasing production limits by 15% for certain controlled substance medicines that were in high demand due to the COVID-19 pandemic. The...
Read More